申请人:MASSACHUSETTS INSTITUTE OF TECHNOLOGY
公开号:US20200316132A1
公开(公告)日:2020-10-08
The present disclosure relates to compositions and methods for treating Williams syndrome (WS), herein identified as a neurodevelopmental oligodendrocyte hypomyelination-associated disease, and to compositions and methods for treatment of other neurodevelopmental myelination abnormality diseases or disorders.